• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    CRH Medical Corporation Announces Majority Acquisition of Lake Washington Anesthesia, PLLC

    Jocelyn Aspa
    Jul. 26, 2018 09:31AM PST
    Medical Device Investing

    CRH Medical (TSX:CRH; NYSE:CRHM) has announced it has completed an accretive transaction where it has acquired a 51 percent interest in a gastroenterology anesthesia practice in the state of Washington. As quoted in the press release: Lake Washington is CRH’s first Monitored Anesthesia Care (“MAC”) program to be completed. The MAC program was announced on March …

    CRH Medical (TSX:CRH; NYSE:CRHM) has announced it has completed an accretive transaction where it has acquired a 51 percent interest in a gastroenterology anesthesia practice in the state of Washington.

    As quoted in the press release:

    Lake Washington is CRH’s first Monitored Anesthesia Care (“MAC”) program to be completed. The MAC program was announced on March 15, 2017 with Puget Sound Gastroenterology (“PSG”). CRH developed PSG’s MAC program and retained an option to acquire a 51% interest in the new anesthesia practice, Lake Washington.

    Lake Washington provides anesthesia services to four GI ambulatory surgical centers and is CRH’s first acquisition in the state of Washington. The transaction was financed through a combination of CRH’s credit facility and cash on hand.

    Lake Washington Transaction Highlights:

    • Estimated annual revenue of US$5.2M
    • EBITDA and cash flow accretive

    Edward Wright, CEO of CRH, commented on the transaction, “Last year, we signed an agreement with Puget Sound Gastroenterology to develop a MAC program to adopt deep sedation as the standard of care at their practice. Today, we are pleased to exercise our option to acquire a majority ownership in the anesthesia practice and expand our footprint to the state of Washington. We look forward to further leveraging the strength of our GI relationships to grow our business through our MAC programs and anesthesia acquisitions.”

    Click here to read the full press release.

    tsx:crhmedical device investingcrh medical
    The Conversation (0)

    Go Deeper

    AI Powered
    Resonance Health Ltd

    Resonance Contracted by Major Global Pharma Company for Clinical Drug Trial Worth $13.775 Million over 24 Months

    Bausch Health Appoints New Chief Medical Officer and Head of R&D

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×